VXLL
Vaxil Bio Ltd. (VXLLF)
Market Closed
8 Jul, 20:00
OTC PINK OTC PINK Primary $
0. 10
0
0%
$
1.37M Market Cap
- P/E Ratio
0% Div Yield
0 Volume
0 Eps
$ 0.1
Previous Close Day Range
0.1 0.1
Year Range
0.01 1
Want to track VXLLF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
VXLLF closed yesterday higher at $0.1, an increase of 0% from Monday's close, completing a monthly decrease of -35.4% or $0.05. Over the past 12 months, VXLLF stock lost -75%.
VXLLF is not paying dividends to its shareholders.
The last earnings report, released on Dec 31, 2016, missed the consensus estimates by -0.01%. On average, the company has fell short of earnings expectations by -0.01%, based on the last three reports.
Vaxil Bio Ltd. has completed 1 stock splits, with the recent split occurring on May 15, 2025.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).
VXLLF Chart
Vaxil Bio Ltd. Dividends
VXLLF is not paying dividends to its shareholders.
Vaxil Bio Ltd. Earnings
| 31 Dec 2016 Date | | - Cons. EPS | - EPS |
| 30 Sep 2016 Date | | - Cons. EPS | - EPS |
| 30 Jun 2016 Date | | - Cons. EPS | - EPS |
| 31 Mar 2016 Date | | - Cons. EPS | - EPS |
| 31 Dec 2015 Date | | - Cons. EPS | - EPS |
VXLLF is not paying dividends to its shareholders.
| 31 Dec 2016 Date | | - Cons. EPS | - EPS |
| 30 Sep 2016 Date | | - Cons. EPS | - EPS |
| 30 Jun 2016 Date | | - Cons. EPS | - EPS |
| 31 Mar 2016 Date | | - Cons. EPS | - EPS |
| 31 Dec 2015 Date | | - Cons. EPS | - EPS |
Vaxil Bio Ltd. (VXLLF) FAQ
What is the stock price today?
The current price is $0.10.
On which exchange is it traded?
Vaxil Bio Ltd. is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is VXLLF.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0%.
What is its market cap?
As of today, the market cap is 1.37M.
Has Vaxil Bio Ltd. ever had a stock split?
Vaxil Bio Ltd. had 1 splits and the recent split was on May 15, 2025.
Vaxil Bio Ltd. Profile
| Biotechnology Industry | Healthcare Sector | Mr. David Goren CEO | OTC PINK Exchange | CA92243L1076 ISIN |
| CA Country | - Employees | - Last Dividend | 15 May 2025 Last Split | - IPO Date |
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment. The company was founded in 2006 and is headquartered in Toronto, Canada.
Contact Information
Address: 3400 One First Canadian Place, Toronto, ON, Canada, M5X 1A4
Phone: -
Website: https://www.vaxil-bio.com
2025 © Marketlog. All Rights Reserved.
